• True once-daily dosing for superior adherence and convenience
• Extended-release metformin dramatically improves gastrointestinal tolerance
• Significant HbA1c reduction with proven cardio-renal protective effects
• Promotes steady, sustainable weight loss and lower blood pressure
• Ideal for patients intolerant to immediate-release metformin

1. Take one Diampa MXR 12.5/1000mg tablet once daily with your evening meal to maximise GI tolerance
2. Swallow the tablet whole with water – do not crush, chew, or break (extended-release)
3. Continue your prescribed diet and exercise programme without interruption
4. Perform regular blood glucose monitoring as advised by your doctor
5. Attend follow-up visits for kidney function, HbA1c, and cardio-renal health checks

Q1: Why choose the XR (extended-release) version over regular Diampa M?
A1: Once-daily dosing + significantly fewer stomach issues while delivering the same powerful results.

Q2: Can I switch directly from twice-daily metformin to Diampa MXR?
A2: Yes – most patients switch seamlessly and notice better tolerability from day one.

Q3: Will I still get the full heart and kidney protection?
A3: Absolutely – Empagliflozin 12.5mg provides the identical clinically proven cardio-renal benefits.

Q4: How much weight loss is typical with this tablet?
A4: Patients usually lose 2–4 kg in the first 6 months due to urinary glucose and calorie loss.

Q5: Is hypoglycemia a concern with Diampa MXR?
A5: Very low risk when used alone or with other non-hypo-causing medicines.

• Not suitable for type 1 diabetes or diabetic ketoacidosis
• Risk of lactic acidosis (metformin-related) – contraindicated if eGFR <30 mL/min or during serious illness
• Maintain good hydration to avoid volume depletion from Empagliflozin
• Watch for genital fungal infections or urinary tract infections
• Long-term use may reduce vitamin B12 levels – annual monitoring suggested
• Store below 30°C, protected from moisture; keep away from children